<DOC>
	<DOC>NCT01482117</DOC>
	<brief_summary>The aim of this study is to investigate the effects of genetic polymorphisms on pharmacokinetic and pharmacodynamic interactions of clopidogrel and cilostazol in Korean healthy adult volunteers.</brief_summary>
	<brief_title>The Effect of Genetic Polymorphism on Interactions of Clopidogrel and Cilostazol in Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Cilostazol</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<criteria>Healthy male subject whose CYP2C19 genotype was determined Subject who has abnormal laboratory test results</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>CYP2C19</keyword>
	<keyword>CYP3A5</keyword>
	<keyword>Clopidogrel</keyword>
	<keyword>Cilostazol</keyword>
	<keyword>Healthy</keyword>
</DOC>